# Alpha Tau Medical (DRTS) — Analyst Forecast

DRTS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/drts/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 4 | 1 | 0 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 3, 2026 | Barclays | Maintained | Overweight | $30.00 |
| Aug 11, 2026 | HC Wainwright & Co. | Maintained | Buy | $16.00 |
| Jul 22, 2026 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| Jul 16, 2026 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| Jun 4, 2026 | Barclays | Maintained | Overweight | $17.00 |
| Jun 4, 2026 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| Jun 2, 2026 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| May 28, 2026 | Barclays | Initiated Coverage | Overweight | $15.00 |
| May 20, 2026 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| May 19, 2026 | Piper Sandler | Maintained | Neutral | $8.00 |
| May 12, 2026 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| May 12, 2026 | Ladenburg Thalmann | Maintained | Buy | $14.00 |
| Mar 11, 2026 | Citigroup | Maintained | Buy | $9.00 |
| Mar 10, 2026 | HC Wainwright & Co. | Maintained | Buy | $12.00 |
| Mar 4, 2026 | Piper Sandler | Downgraded | Overweight → Neutral | $5.00 |
| Feb 24, 2026 | HC Wainwright & Co. | Maintained | Buy | $12.00 |
| Dec 10, 2025 | Citigroup | Maintained | Buy | $7.00 |
| Nov 24, 2025 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Oct 22, 2025 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Sep 3, 2025 | HC Wainwright & Co. | Maintained | Buy | $9.00 |

## Frequently Asked Questions

### Is DRTS a buy, sell, or hold?

Analysts covering Alpha Tau Medical currently average a Buy rating: 4 buy, 1 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on DRTS?

On Sep 3, 2026, Barclays maintained Alpha Tau Medical at Overweight with a price target of $30.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).